(CercleFinance.com) – Pixium Vision announced on Wednesday that the French justice system had decided to postpone its decision concerning the approval of a sale plan and the opening of judicial liquidation proceedings.
The Paris Commercial Court was supposed to rule on December 18 on the only takeover offer received to date by the judicial administrators of the bionic vision specialist.
On this occasion, the courts also had to rule on the follow-up to be given to the liquidation procedure involving the inventor of the Prima wireless photovoltaic subretinal micro-implant.
As a reminder, the group must communicate the results of a trial carried out on its system in 38 patients suffering from severe deterioration of the central visual field due to dry AMD during the second trimester.
As of November 20, the deadline for submitting offers, only one takeover offer had been submitted.
Pixium indicates that it plans to communicate the date on which the court intends to rule as soon as it becomes aware of it.
Several times reserved for an increase following this announcement, Pixium shares posted a gain of more than 17% late Wednesday morning on the Paris Stock Exchange, investors regaining hope in the future of the company.
Copyright © 2024 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends using the buttons below.
